Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGHD1-20 is a diversity (D) gene segment in the immunoglobulin heavy chain locus (IGH) on chromosome 14. It encodes a short stretch of amino acids incorporated into the variable region of immunoglobulin heavy chains through somatic V(D)J recombination in developing B cells[1][3]. Multiple IGHD segments (including IGHD1-20) exist to increase the diversity of the antigen-binding sites of antibodies[1][3]. IGHD1-20 is not itself a receptor, enzyme, or drug target; instead, it is a genetic component required for the immense variability of immunoglobulins central to adaptive immunity[1][3].\n\nImmunoglobulin D segments such as IGHD1-20 are not directly expressed as proteins but are recombined during B cell development to produce variable regions of antibody heavy chains, together with V (variable) and J (joining) segments[1][3]. Entries like "IGHD1-20" do not represent druggable or functional protein targets, nor do they act as standalone disease biomarkers or receptors. In summary, IGHD1-20 is an immunoglobulin heavy chain diversity gene segment, not a therapeutic or functional target, and its inclusion as a target or receptor is a misclassification[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy diversity 1-20 (IGHD1-20).